Robert W. Baird Begins Coverage on Oscar Health (NYSE:OSCR)

Robert W. Baird initiated coverage on shares of Oscar Health (NYSE:OSCR – Free Report) in a research report sent to investors on Thursday morning, Marketbeat reports. The firm issued an outperform rating and a $28.00 price objective on the stock. OSCR has been the subject of several other reports. The Goldman Sachs Group increased their […]

Leave a Reply

Your email address will not be published.

Previous post HC Wainwright Reiterates “Buy” Rating for BioNTech (NASDAQ:BNTX)
Next post Malibu Boats (NASDAQ:MBUU) Downgraded by StockNews.com